• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Exploring the relationship between β-adrenergic receptor kinase-1 and physical symptoms in heart failure.探索β-肾上腺素能受体激酶-1与心力衰竭身体症状之间的关系。
Heart Lung. 2018 Jul-Aug;47(4):281-284. doi: 10.1016/j.hrtlng.2018.05.003. Epub 2018 May 24.
2
The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.自发性高血压性心力衰竭(SHHF)大鼠的心肌β-肾上腺素能系统
Hypertension. 1999 Jan;33(1 Pt 2):402-7. doi: 10.1161/01.hyp.33.1.402.
3
Sympathetic dysfunction is associated with worse fatigue and early and subtle symptoms in heart failure: an exploratory sex-stratified analysis.交感神经功能障碍与心力衰竭中更严重的疲劳以及早期和细微症状相关:一项探索性性别分层分析。
Eur J Cardiovasc Nurs. 2024 Jul 19;23(5):532-539. doi: 10.1093/eurjcn/zvad121.
4
In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.在体内抑制杂交转基因小鼠心肌中升高的β-肾上腺素能受体激酶活性可恢复正常的β-肾上腺素能信号传导和功能。
Circulation. 1999 Aug 10;100(6):648-53. doi: 10.1161/01.cir.100.6.648.
5
Hypertensive left ventricular hypertrophy: relation to beta-adrenergic receptor kinase-1 (betaARK1) in peripheral lymphocytes.高血压性左心室肥厚:与外周淋巴细胞中β-肾上腺素能受体激酶-1(βARK1)的关系
J Hypertens. 2004 May;22(5):1025-32. doi: 10.1097/00004872-200405000-00026.
6
Identifying a Relationship Between Physical Frailty and Heart Failure Symptoms.确定身体虚弱与心力衰竭症状之间的关系。
J Cardiovasc Nurs. 2018 Jan/Feb;33(1):E1-E7. doi: 10.1097/JCN.0000000000000408.
7
Sympathetic Markers are Different Between Clinical Responders and Nonresponders After Left Ventricular Assist Device Implantation.在植入左心室辅助装置后,临床应答者和无应答者的交感神经标志物不同。
J Cardiovasc Nurs. 2019 Jul/Aug;34(4):E1-E10. doi: 10.1097/JCN.0000000000000580.
8
Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure.终末期人类心力衰竭中磷酸肌醇3激酶γ活性及β-肾上腺素能受体转运的动态调节
Circulation. 2007 Nov 27;116(22):2571-9. doi: 10.1161/CIRCULATIONAHA.107.706515. Epub 2007 Nov 12.
9
Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.通过基因转移对衰竭人类心脏中的靶向β-肾上腺素能受体激酶(βARK1)进行抑制。
Circulation. 2004 Apr 6;109(13):1590-3. doi: 10.1161/01.CIR.0000125521.40985.28. Epub 2004 Mar 29.
10
Psychometric Analysis of the Heart Failure Somatic Perception Scale as a Measure of Patient Symptom Perception.心力衰竭躯体感知量表作为患者症状感知测量工具的心理测量分析
J Cardiovasc Nurs. 2017 Mar/Apr;32(2):140-147. doi: 10.1097/JCN.0000000000000320.

引用本文的文献

1
Hitting the (bio)mark Part 2: analysing, interpreting, and reporting biomarker data in cardiovascular research.命中(生物)标记物 第二部分:心血管研究中生物标志物数据的分析、解释和报告。
Eur J Cardiovasc Nurs. 2024 Oct 21;23(7):818-824. doi: 10.1093/eurjcn/zvae020.
2
Sympathetic dysfunction is associated with worse fatigue and early and subtle symptoms in heart failure: an exploratory sex-stratified analysis.交感神经功能障碍与心力衰竭中更严重的疲劳以及早期和细微症状相关:一项探索性性别分层分析。
Eur J Cardiovasc Nurs. 2024 Jul 19;23(5):532-539. doi: 10.1093/eurjcn/zvad121.
3
Spanish version of the Heart Failure Somatic Perception Scale (HFSPS v.3) - psychometric properties.心力衰竭躯体感知量表(HFSPS v.3)西班牙语版本——心理测量特性
Front Cardiovasc Med. 2023 Dec 1;10:1242057. doi: 10.3389/fcvm.2023.1242057. eCollection 2023.
4
Cross-classification of physical and affective symptom clusters and 180-day event-free survival in moderate to advanced heart failure.中重度心力衰竭患者躯体和情感症状群的交叉分类与 180 天无事件生存的关系。
Heart Lung. 2020 Mar-Apr;49(2):151-157. doi: 10.1016/j.hrtlng.2019.11.004. Epub 2019 Nov 18.
5
Sympathetic Markers are Different Between Clinical Responders and Nonresponders After Left Ventricular Assist Device Implantation.在植入左心室辅助装置后,临床应答者和无应答者的交感神经标志物不同。
J Cardiovasc Nurs. 2019 Jul/Aug;34(4):E1-E10. doi: 10.1097/JCN.0000000000000580.
6
Heart Failure Symptom Biology in Response to Ventricular Assist Device Implantation.心力衰竭症状生物学对心室辅助装置植入的反应。
J Cardiovasc Nurs. 2019 Mar-Apr;34(2):174-182. doi: 10.1097/JCN.0000000000000552.
7
Comparative symptom biochemistry between moderate and advanced heart failure.中度与重度心力衰竭的症状生物化学比较
Heart Lung. 2018 Nov;47(6):565-575. doi: 10.1016/j.hrtlng.2018.09.002. Epub 2018 Oct 9.

本文引用的文献

1
GRK2 as a therapeutic target for heart failure.GRK2作为心力衰竭的治疗靶点。
Expert Opin Ther Targets. 2018 Jan;22(1):75-83. doi: 10.1080/14728222.2018.1406925. Epub 2017 Nov 23.
2
Symptom burden in heart failure: assessment, impact on outcomes, and management.心力衰竭中的症状负担:评估、对预后的影响及管理
Heart Fail Rev. 2017 Jan;22(1):25-39. doi: 10.1007/s10741-016-9581-4.
3
The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.不断扩展的G蛋白偶联受体激酶相互作用组:对心血管疾病的影响及治疗开发潜力
Pharmacol Res. 2016 Aug;110:52-64. doi: 10.1016/j.phrs.2016.05.008. Epub 2016 May 12.
4
Psychometric Analysis of the Heart Failure Somatic Perception Scale as a Measure of Patient Symptom Perception.心力衰竭躯体感知量表作为患者症状感知测量工具的心理测量分析
J Cardiovasc Nurs. 2017 Mar/Apr;32(2):140-147. doi: 10.1097/JCN.0000000000000320.
5
Gender-Specific Physical Symptom Biology in Heart Failure.心力衰竭中的性别特异性身体症状生物学
J Cardiovasc Nurs. 2015 Nov-Dec;30(6):517-21. doi: 10.1097/JCN.0000000000000191.
6
Depressive symptoms and the relationship of inflammation to physical signs and symptoms in heart failure patients.心力衰竭患者的抑郁症状以及炎症与身体体征和症状的关系。
Am J Crit Care. 2014 Sep;23(5):404-13. doi: 10.4037/ajcc2014614.
7
Symptom-Hemodynamic Mismatch and Heart Failure Event Risk.症状-血流动力学不匹配与心力衰竭事件风险
J Cardiovasc Nurs. 2015 Sep-Oct;30(5):394-402. doi: 10.1097/JCN.0000000000000175.
8
Physical and psychological symptom biomechanics in moderate to advanced heart failure.中重度心力衰竭的身体和心理症状生物力学
J Cardiovasc Nurs. 2015 Jul-Aug;30(4):346-50. doi: 10.1097/JCN.0000000000000171.
9
Background and design of the profiling biobehavioral responses to mechanical support in advanced heart failure study.晚期心力衰竭中对机械支持的生物行为反应剖析研究的背景与设计
J Cardiovasc Nurs. 2014 Sep-Oct;29(5):405-15. doi: 10.1097/JCN.0b013e318299fa09.
10
Symptoms in heart failure correlate poorly with objective haemodynamic parameters.心力衰竭的症状与客观血流动力学参数相关性差。
Int J Clin Pract. 2012 Dec;66(12):1224-9. doi: 10.1111/j.1742-1241.2012.03003.x.

探索β-肾上腺素能受体激酶-1与心力衰竭身体症状之间的关系。

Exploring the relationship between β-adrenergic receptor kinase-1 and physical symptoms in heart failure.

作者信息

Denfeld Quin E, Mudd James O, Hasan Wohaib, Gelow Jill M, Hiatt Shirin O, Winters-Stone Kerri, Lee Christopher S

机构信息

Oregon Health & Science University School of Nursing, Portland, OR, USA.

Oregon Health & Science University Knight Cardiovascular Institute, Portland, OR, USA.

出版信息

Heart Lung. 2018 Jul-Aug;47(4):281-284. doi: 10.1016/j.hrtlng.2018.05.003. Epub 2018 May 24.

DOI:10.1016/j.hrtlng.2018.05.003
PMID:29803296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7295114/
Abstract

BACKGROUND

The relationship between physical heart failure (HF) symptoms and pathophysiological mechanisms is unclear.

OBJECTIVE

To quantify the relationship between plasma β-adrenergic receptor kinase-1 (βARK1) and physical symptoms among adults with HF.

METHODS

We performed a secondary analysis of data collected from two studies of adults with HF. Plasma βARK1 was quantified using an enzyme-linked immunosorbent assay. Physical symptoms were measured with the HF Somatic Perception Scale (HFSPS). Generalized linear modeling was used to quantify the relationship between βARK1 and HFSPS scores.

RESULTS

The average age (n = 94) was 54.5 ± 13.1 years, 76.6% were male, and a majority (83.0%) had Class III or IV HF. βARK1 was significantly associated with HFSPS scores (β = 0.22 ± 0.10, p = 0.038), adjusting for other predictors of physical symptoms (model R = 0.250, F(7, 70) = 3.34, p = 0.004).

CONCLUSIONS

Higher βARK1 is associated with worse physical HF symptoms, pinpointing a potential pathophysiologic underpinning.

摘要

背景

心力衰竭(HF)的身体症状与病理生理机制之间的关系尚不清楚。

目的

量化血浆β-肾上腺素能受体激酶-1(βARK1)与成年HF患者身体症状之间的关系。

方法

我们对两项成年HF患者研究收集的数据进行了二次分析。使用酶联免疫吸附测定法对血浆βARK1进行定量。用HF躯体感知量表(HFSPS)测量身体症状。采用广义线性模型量化βARK1与HFSPS评分之间的关系。

结果

平均年龄(n = 94)为54.5±13.1岁,76.6%为男性,大多数(83.0%)患有Ⅲ级或Ⅳ级HF。在调整身体症状的其他预测因素后,βARK1与HFSPS评分显著相关(β = 0.22±0.10,p = 0.038)(模型R = 0.250,F(7, 70) = 3.34,p = 0.004)。

结论

较高的βARK1与更严重的HF身体症状相关,确定了潜在的病理生理基础。